The global exotic pets market size is expected to reach USD 3.21 billion by 2033, registering a CAGR of 8.1% from 2026 to 2033, according to a new report by Grand View Research, Inc. The market is expanding due to increasing consumer interest in unique and non-traditional companion animals. Rising urbanization has led many individuals to seek pets that require less space and offer novelty. Millennials and Gen Z consumers strongly prefer reptiles, amphibians, birds, and small mammals as alternatives to conventional pets. Social media platforms have amplified the visibility of exotic pets, influencing ownership trends across urban and semi-urban regions. As a result, demand is growing steadily, particularly in North America, Europe, and parts of Asia Pacific.
Improved access to specialized veterinary services and exotic pet care products supports market expansion. Veterinary clinics and pet stores increasingly cater to exotic species with tailored services, diets, and habitat supplies. Online platforms are playing a major role in educating potential owners and offering products that meet the specific needs of these animals. Developing species-specific nutrition and medical care has strengthened consumer confidence in maintaining exotic pets. This increased accessibility has contributed to these animals' broader acceptance and appeal among pet enthusiasts.
Changing lifestyle preferences and emotional well-being contribute to exotic pets' popularity. People seek companionship that aligns with their personalities and living environments, often choosing pets that reflect individual expression. The therapeutic benefits of observing and interacting with exotic animals drive interest in species such as turtles, geckos, and parrots. Growing disposable incomes and the humanization of pets further encourage consumers to invest in non-traditional species. These trends will sustain demand and fuel market growth through the forecast period.
Request a free sample copy or view report summary: Exotic Pets Market Report
Pharmaceuticals segment dominated the market with the largest revenue share of 69.51% in 2025. The segment is comprised of anti-inflammatories, parasiticides, antibiotics, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs
Small mammals segment dominated with the largest revenue share in 2025, driven by urbanization, changing lifestyles, and a growing preference for compact and low-maintenance pets.
Oral segment held the largest revenue share in 2025, owing to its ease of use and efficiency, particularly for exotic pets such as reptiles, birds, and small mammals.
Bacterial infection segment dominated the market in 2025. Bacterial infections in exotic companion animals are commonly caused by poor husbandry, stress, or exposure to infected animals, leading to respiratory, gastrointestinal, skin, and systemic diseases
North America exotic pets market dominated with the largest revenue share of 50.02% in 2025. The market is driven by urban lifestyles and increased exposure to exotic species through social media increasing pet ownership preferences
Grand View Research has segmented the global exotic pets market report based on product, animal, route of administration, indication, distribution channel, and region:
Exotic Pets Product Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceuticals
Parasiticides
Antibiotics
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Others
Nutritional Supplements
Exotic Pets Animal Outlook (Revenue, USD Million, 2021 - 2033)
Small Mammals
Birds
Reptiles
Others
Exotic Pets Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
Oral
Injectable
Topical
Exotic Pets Indication Outlook (Revenue, USD Million, 2021 - 2033)
Bacterial infection
Parasitic infection
Orthopedic diseases
Others
Exotic Pets Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
Veterinary Hospitals & Clinics
E-commerce
Retail
Exotic Pets Region Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
UAE
Saudi Arabia
Kuwait
Qatar
Oman
List of Key Players in the Exotic Pets Market
AdvaCare Pharma
VETARK (Candioli Srl)
Vetafarm
Mazuri
Versele Laga
CROCdoc (a sister company of The Birdcare Company)
Zoetis Inc.
Merck & Co., Inc
Vetnil
Pet King Brands
"The quality of research they have done for us has been excellent..."